Benzinga | May 5, 2021 07:22AM EDT

Baudax Bio Q1 EPS $(0.27) Misses $(0.19) Estimate

Baudax Bio (NASDAQ:BXRX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.19) by 42.11 percent. This is a 93.3 percent increase over losses of $(4.03) per share from the same period last year.